Literature DB >> 21540290

GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation.

Amal Zerrad-Saadi1, Martine Lambert-Blot, Claudia Mitchell, Hugo Bretes, Alexandra Collin de l'Hortet, Véronique Baud, Fanny Chereau, Athanassia Sotiropoulos, John J Kopchick, Lan Liao, Jianming Xu, Hélène Gilgenkrantz, Jacques-Emmanuel Guidotti.   

Abstract

GH is a pleiotropic hormone that plays a major role in proliferation, differentiation, and metabolism via its specific receptor. It has been previously suggested that GH signaling pathways are required for normal liver regeneration but the molecular mechanisms involved have yet to be determined. The aim of this study was to identify the mechanisms by which GH controls liver regeneration. We performed two thirds partial hepatectomies in GH receptor (GHR)-deficient mice and wild-type littermates and showed a blunted progression in the G(1)/S transition phase of the mutant hepatocytes. This impaired liver regeneration was not corrected by reestablishing IGF-1 expression. Although the initial response to partial hepatectomy at the priming phase appeared to be similar between mutant and wild-type mice, cell cycle progression was significantly blunted in mutant mice. The main defect in GHR-deficient mice was the deficiency of the epidermal growth factor receptor activation during the process of liver regeneration. Finally, among the pathways activated downstream of GHR during G(1) phase progression, namely Erk1/2, Akt, and signal transducer and activator of transcription 3, we only found a reduced Erk1/2 phosphorylation in mutant mice. In conclusion, our results demonstrate that GH signaling plays a major role in liver regeneration and strongly suggest that it acts through the activation of both epidermal growth factor receptor and Erk1/2 pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21540290     DOI: 10.1210/en.2010-1193

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

1.  The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.

Authors:  Hao-Long Qi; Chang-Sheng Li; Chong-Wei Qian; Yu-Sha Xiao; Yu-Feng Yuan; Quan-Yan Liu; Zhi-Su Liu
Journal:  Tumour Biol       Date:  2015-08-14

2.  Meloxicam increases epidermal growth factor receptor expression improving survival after hepatic resection in diet-induced obese mice.

Authors:  Xiaoling Jin; Teresa A Zimmers; Yanlin Jiang; Daniel P Milgrom; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Surgery       Date:  2018-02-01       Impact factor: 3.982

Review 3.  The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.

Authors:  Carmen Berasain; Matías A Avila
Journal:  J Gastroenterol       Date:  2013-12-10       Impact factor: 7.527

4.  Epidermal growth factor receptor restoration rescues the fatty liver regeneration in mice.

Authors:  Teresa A Zimmers; Xiaoling Jin; Zongxiu Zhang; Yanlin Jiang; Leonidas G Koniaris
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-06-27       Impact factor: 4.310

5.  Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.

Authors:  Xiaoling Jin; Teresa A Zimmers; Zongxiu Zhang; Leonidas G Koniaris
Journal:  Dig Dis Sci       Date:  2018-10-03       Impact factor: 3.199

6.  Prognostic gene biomarker identification in liver cancer by data mining.

Authors:  Gang Liu; Haitao Tang; Chen Li; Haiyan Zhen; Zhigang Zhang; Yongzhong Sha
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration.

Authors:  Ryota Masuzaki; Sophia Zhao; M Todd Valerius; Daisuke Tsugawa; Yuki Oya; Kevin C Ray; Seth J Karp
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

8.  Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.

Authors:  Patricia Stiedl; Robert McMahon; Leander Blaas; Victoria Stanek; Jasmin Svinka; Beatrice Grabner; Gernot Zollner; Sonja M Kessler; Thierry Claudel; Mathias Müller; Wolfgang Mikulits; Martin Bilban; Harald Esterbauer; Robert Eferl; Johannes Haybaeck; Michael Trauner; Emilio Casanova
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

9.  Mesenchymal growth hormone receptor deficiency leads to failure of alveolar progenitor cell function and severe pulmonary fibrosis.

Authors:  Ting Xie; Vrishika Kulur; Ningshan Liu; Nan Deng; Yizhou Wang; Simon Coyle Rowan; Changfu Yao; Guanling Huang; Xue Liu; Forough Taghavifar; Jiurong Liang; Cory Hogaboam; Barry Stripp; Peter Chen; Dianhua Jiang; Paul W Noble
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

10.  Low Growth Hormone Levels Predict Poor Outcome of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Authors:  Daxian Wu; Lingjian Zhang; Shanshan Ma; Yalei Zhao; Ronggao Chen; Fen Zhang; Qiuhong Liu; Xiaowei Xu; Zhongyang Xie
Journal:  Front Med (Lausanne)       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.